Predictors of long‐term survival in Japanese patients with heart failure with reduced ejection fraction (HFrEF) treated with cardiac resynchronization therapy‐defibrillators (CRT‐D)

Author:

Sakaguchi Yuta1,Izumi Daisuke1,Wada Rhythm1,Akagawa Rie1,Suzuki Naomasa1,Hakamata Takahiro1,Ikami Yasuhiro1,Hasegaw Yuki1,Otsuki Sou1ORCID,Yagihara Nobue1,Iijima Kenichi1,Inomata Takayuki1

Affiliation:

1. Department of Cardiovascular Medicine Niigata University Graduate School of Medical and Dental Sciences Niigata Japan

Abstract

AbstractBackgroundReports on the factors predicting long‐term survival of CRT‐D cases from Western countries are increasing, however, those from Asia including Japan are still sparse. We aimed to clarify the factors predicting long‐term survival of Japanese CRT‐D cases.MethodsWe retrospectively analyzed consecutive 133 patients who underwent CRT‐D implantation between 2006 and 2021. We compared clinical factors between patients who died within 5 years after implantation (short‐survival group: n = 31) and who had survived for more than 5 years (long‐survival group: n = 36) after implantation.ResultsMajor underlying heart diseases were dilated cardiomyopathy (45%) and ischemic heart disease (12%). There was no difference between the short‐survival group and the long‐survival group in incidence of CLBBB (32% vs. 30%), whereas CRBBB was more common in the short‐survival group (26% vs. 0%, p = .004). Mechanical dyssynchrony at implantation was more frequent in the long‐survival group (48% vs. 78%, p = .02). The incidence of response to CRT at 1 year after implantation was higher in long‐survival group (19% vs. 50%, p = .02). Multiple logistic regression analysis identified NYHA class, mechanical dyssynchrony at implantation, and response at one year as predictors of long‐term survival.ConclusionsIn Japanese CRT‐D cases, lower NHYA class, preexisting mechanical dyssynchrony, and 1‐year response to CRT predict long‐term survival.

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine,General Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3